2026 Evelien Smits: Immunology Researcher – H-Index, Publications & Awards

Discipline name	D-Index	World Ranking	Current World Ranking	National Ranking	Current National Ranking	Publications	Citations
Immunology	56	3746	3456	56	54	190	10076

Overview

Evelien Smits is affiliated with the University of Antwerp in Belgium and has an extensive publication record within the fields of Medicine and Immunology and Microbiology. Their research spans various subfields including Oncology, Immunology, Molecular Biology, Pulmonary and Respiratory Medicine, and Biomedical Engineering.

Their scientific contributions focus primarily on topics related to cancer and immunotherapy. Key themes in their research include:

Cancer Immunotherapy and Biomarkers
Immunotherapy and Immune Responses
Immune Cell Function and Interaction
Cancer Cells and Metastasis
CAR-T cell therapy research
Nanoplatforms for cancer theranostics
Plasma Applications and Diagnostics

Among their recent publications are:

"The CD70-CD27 axis in oncology: the new kids on the block," 2022, Journal of Experimental & Clinical Cancer Research
"Challenges in neoantigen-directed therapeutics," 2022, Cancer Cell
"Trial watch: Dendritic cell (DC)-based immunotherapy for cancer," 2022, OncoImmunology
"Auranofin reveals therapeutic anticancer potential by triggering distinct molecular cell death mechanisms and innate immunity in mutant p53 non-small cell lung cancer," 2021, Redox Biology
"A systematic review on poly(I:C) and poly-ICLC in glioblastoma: adjuvants coordinating the unlocking of immunotherapy," 2021, Journal of Experimental & Clinical Cancer Research

Evelien Smits frequently collaborates with a select group of researchers, including Filip Lardon, Annemie Bogaerts, Christophe Deben, Marc Peeters, and Abraham Lin.

Their work is commonly published in scientific venues such as:

Cancers
Zenodo (CERN European Organization for Nuclear Research)
bioRxiv (Cold Spring Harbor Laboratory)
OncoImmunology
Redox Biology

Best Publications

Clinical use of dendritic cells for cancer therapy

SÃ©bastien Anguille;Evelien L. Smits;Eva Lion;Viggo F. van Tendeloo

791
Citations
Induction of complete and molecular remissions in acute myeloid leukemia by Wilms’ tumor 1 antigen-targeted dendritic cell vaccination

Viggo F. van Tendeloo;Ann Van de Velde;Ann van Driessche;Nathalie Cools

460
Citations
CD56 in the Immune System: More Than a Marker for Cytotoxicity?

Heleen H. Van Acker;Anna Capsomidis;Evelien L. Smits;Viggo F. Van Tendeloo

392
Citations
The potential and controversy of targeting STAT family members in cancer

Yannick Verhoeven;Sam Tilborghs;Julie Jacobs;Jorrit De Waele

302
Citations
The Use of TLR7 and TLR8 Ligands for the Enhancement of Cancer Immunotherapy

Evelien L. J. M. Smits;Peter Ponsaerts;Zwi N. Berneman;Viggo F. I. Van Tendeloo

285
Citations
Non‐Thermal Plasma as a Unique Delivery System of Short‐Lived Reactive Oxygen and Nitrogen Species for Immunogenic Cell Death in Melanoma Cells

Abraham Lin;Yury Gorbanev;Joey De Backer;Jinthe Van Loenhout

236
Citations
Dendritic cell vaccination as postremission treatment to prevent or delay relapse in acute myeloid leukemia

Sébastien Anguille;Ann L. Van De Velde;Evelien L. Smits;Viggo F. Van Tendeloo

231
Citations
CD70: An emerging target in cancer immunotherapy

J. Jacobs;V. Deschoolmeester;K. Zwaenepoel;C. Rolfo

224
Citations
Bisphosphonates for cancer treatment: Mechanisms of action and lessons from clinical trials.

Heleen H. Van Acker;SÃ©bastien Anguille;Yannick Willemen;Evelien L. Smits

220
Citations
Poly(I:C) as cancer vaccine adjuvant: Knocking on the door of medical breakthroughs

Rachid Ammi;Jorrit De Waele;Yannick Willemen;Ilse Van Brussel

201
Citations
Natural killer cell immune escape in acute myeloid leukemia

E Lion;Y Willemen;Z N Berneman;V F I Van Tendeloo

185
Citations
Dendritic Cells as Pharmacological Tools for Cancer Immunotherapy

SÃ©bastien Anguille;Evelien L. Smits;Christian Bryant;Heleen H. Van Acker

176
Citations
Trial watch: Dendritic cell (DC)-based immunotherapy for cancer

Unknown

159
Citations
Challenges in neoantigen-directed therapeutics.

Unknown

150
Citations
Inborn errors in RNA polymerase III underlie severe varicella zoster virus infections

Benson Ogunjimi;Shen-Ying Zhang;Katrine Biehl Sørensen;Kristian A Skipper

146
Citations
RNA-based gene transfer for adult stem cells and T cells.

E Smits;P Ponsaerts;M Lenjou;G Nijs

144
Citations
Human plasmacytoid dendritic cells are equipped with antigen-presenting and tumoricidal capacities

Jurjen Tel;Evelien L. Smits;Sébastien Anguille;Rubin N. Joshi

133
Citations
Interferon-α in acute myeloid leukemia: an old drug revisited

S Anguille;E Lion;Y Willemen;V F I Van Tendeloo

132
Citations
mRNA-based dendritic cell vaccination induces potent antiviral T-cell responses in HIV-1-infected patients.

Ellen van Gulck;Erika Vlieghe;Marc Vekemans;Viggo V.F. van Tendeloo

130
Citations
Anti-cancer capacity of plasma-treated PBS: effect of chemical composition on cancer cell cytotoxicity.

Wilma Van Boxem;Jonas Van der Paal;Yury Gorbanev;Steven Vanuytsel

123
Citations
Immunosuppression induced by immature dendritic cells is mediated by TGF‐β/IL‐10 double‐positive CD4+ regulatory T cells

N. Cools;V.F.I. Van Tendeloo;E.L.J.M. Smits;M. Lenjou

123
Citations
Short-term cultured, interleukin-15 differentiated dendritic cells have potent immunostimulatory properties

SÃ©bastien Anguille;Evelien L.J.M. Smits;Nathalie Cools;Herman Goossens

117
Citations
Expansion of a BDCA1+CD14+ Myeloid Cell Population in Melanoma Patients May Attenuate the Efficacy of Dendritic Cell Vaccines

Ghaith Bakdash;Sonja I. Buschow;Mark A.J. Gorris;Altuna Halilovic

114
Citations

Frequent Co-Authors

Viggo Van Tendeloo University of Antwerp

Zwi N. Berneman University of Antwerp

Patrick Pauwels University of Antwerp

Marc Peeters University of Antwerp

Annemie Bogaerts University of Antwerp

Niel Hens Hasselt University

Herman Goossens University of Antwerp

I. Jolanda M. de Vries Radboud University

Sylvia Dewilde University of Antwerp

Haruo Sugiyama Osaka University

External Links

Personal website of Evelien Smits

If you think any of the details on this page are incorrect, let us know.

Related Online Degrees & Career Pathways

Studying Immunology in the USA opens doors to diverse career pathways, especially in healthcare and research. Many graduates consider advancing their education through specialized nursing programs to complement their immunology expertise. For those interested in nursing, exploring an accelerated FNP program can fast-track their path to becoming a Family Nurse Practitioner while gaining valuable clinical skills.

Transitioning from an FNP role to an acute care setting is another viable route, often requiring additional certification. Understanding the requirements for acute care NP certification is crucial for those aiming to serve patients with complex immunological and critical care needs.

For individuals without prior nursing experience, 12-month accelerated nursing programs online offer an efficient way to enter the field. These 12-month accelerated nursing programs online for non nurses combine flexibility with rigorous training, providing a solid foundation for immunology-related healthcare roles.

Salary potential varies widely depending on specialty and location. Prospective students and professionals should refer to resources like dnp salary by specialty to understand earning prospects and make informed career decisions.